Torsade de pointes (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Torsade de pointes" in Polish language version.

refsWebsite
Global rank Polish rank
5th place
2nd place
2nd place
6th place
4th place
7th place
low place
1,068th place
8,738th place
165th place
3,918th place
92nd place

doi.org

dx.doi.org

  • Jan Albert Nicolaas Groot, Leonore Ten Bokum, Hubertus Laurentius Antonius van den Oever, Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose, „Journal of Intensive Care”, 6, 2018, s. 59, DOI10.1186/s40560-018-0329-1, ISSN 2052-0492, PMID30214811, PMCIDPMC6131849 [dostęp 2020-04-28].
  • Ankavipar Saprungruang i inni, Genotype and clinical characteristics of congenital long QT syndrome in Thailand, „Indian Pacing and Electrophysiology Journal”, 18 (5), 2018, s. 165–171, DOI10.1016/j.ipej.2018.07.007, ISSN 0972-6292, PMID30036649, PMCIDPMC6198685 [dostęp 2020-04-28].
  • Peter J. Schwartz, Raymond L. Woosley, Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes, „Journal of the American College of Cardiology”, 67 (13), 2016, s. 1639–1650, DOI10.1016/j.jacc.2015.12.063, ISSN 1558-3597, PMID27150690 [dostęp 2020-04-28].
  • Pascal Champeroux i inni, Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres, „British Journal of Pharmacology”, 144 (3), 2005, s. 376–385, DOI10.1038/sj.bjp.0706070, ISSN 0007-1188 [dostęp 2020-04-28].
  • T.L. Lenz, D.E. Hilleman, Dofetilide, a new class III antiarrhythmic agent, „Pharmacotherapy”, 20 (7), 2000, s. 776–786, DOI10.1592/phco.20.9.776.35208, ISSN 0277-0008, PMID10907968 [dostęp 2020-04-28].
  • Tao Yang i inni, Screening for Acute IKr Block is Insufficient to Detect Torsades de Pointes Liability: Role of Late Sodium Current, „Circulation”, 130 (3), 2014, s. 224–234, DOI10.1161/circulationaha.113.007765, ISSN 0009-7322 [dostęp 2020-04-28].
  • Yee Guan Yap, A. John Camm, Drug induced QT prolongation and torsades de pointes, „Heart (British Cardiac Society)”, 89 (11), 2003, s. 1363–1372, DOI10.1136/heart.89.11.1363, ISSN 1468-201X, PMID14594906, PMCIDPMC1767957 [dostęp 2020-04-28].
  • Jinu John i inni, Torsade de Pointes due to Methadone Use in a Patient with HIV and Hepatitis C Coinfection, „Cardiology Research and Practice”, 2010, 2010, s. 524764, DOI10.4061/2010/524764, ISSN 2090-0597, PMID21253542, PMCIDPMC3021856 [dostęp 2020-04-28].
  • Simon H.L. Thomas, Elijah R. Behr, Pharmacological treatment of acquired QT prolongation and torsades de pointes, „British Journal of Clinical Pharmacology”, 81 (3), 2016, s. 420–427, DOI10.1111/bcp.12726, ISSN 1365-2125, PMID26183037, PMCIDPMC4767204 [dostęp 2020-04-28].
  • Kenji Hoshino i inni, Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome, „Pediatrics International: Official Journal of the Japan Pediatric Society”, 48 (2), 2006, s. 112–117, DOI10.1111/j.1442-200X.2006.02177.x, ISSN 1328-8067, PMID16635167 [dostęp 2020-04-28].
  • Silvia G. Priori i inni, 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), „Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology”, 17 (11), 2015, s. 1601–1687, DOI10.1093/europace/euv319, ISSN 1532-2092, PMID26318695 [dostęp 2020-04-28].

mp.pl

nih.gov

ncbi.nlm.nih.gov

  • Jan Albert Nicolaas Groot, Leonore Ten Bokum, Hubertus Laurentius Antonius van den Oever, Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose, „Journal of Intensive Care”, 6, 2018, s. 59, DOI10.1186/s40560-018-0329-1, ISSN 2052-0492, PMID30214811, PMCIDPMC6131849 [dostęp 2020-04-28].
  • F. Dessertenne, [Ventricular tachycardia with 2 variable opposing foci], „Archives Des Maladies Du Coeur Et Des Vaisseaux”, 59 (2), 1966, s. 263–272, ISSN 0003-9683, PMID4956181 [dostęp 2020-04-28].
  • Ankavipar Saprungruang i inni, Genotype and clinical characteristics of congenital long QT syndrome in Thailand, „Indian Pacing and Electrophysiology Journal”, 18 (5), 2018, s. 165–171, DOI10.1016/j.ipej.2018.07.007, ISSN 0972-6292, PMID30036649, PMCIDPMC6198685 [dostęp 2020-04-28].
  • Peter J. Schwartz, Raymond L. Woosley, Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes, „Journal of the American College of Cardiology”, 67 (13), 2016, s. 1639–1650, DOI10.1016/j.jacc.2015.12.063, ISSN 1558-3597, PMID27150690 [dostęp 2020-04-28].
  • T.L. Lenz, D.E. Hilleman, Dofetilide, a new class III antiarrhythmic agent, „Pharmacotherapy”, 20 (7), 2000, s. 776–786, DOI10.1592/phco.20.9.776.35208, ISSN 0277-0008, PMID10907968 [dostęp 2020-04-28].
  • Yee Guan Yap, A. John Camm, Drug induced QT prolongation and torsades de pointes, „Heart (British Cardiac Society)”, 89 (11), 2003, s. 1363–1372, DOI10.1136/heart.89.11.1363, ISSN 1468-201X, PMID14594906, PMCIDPMC1767957 [dostęp 2020-04-28].
  • Jinu John i inni, Torsade de Pointes due to Methadone Use in a Patient with HIV and Hepatitis C Coinfection, „Cardiology Research and Practice”, 2010, 2010, s. 524764, DOI10.4061/2010/524764, ISSN 2090-0597, PMID21253542, PMCIDPMC3021856 [dostęp 2020-04-28].
  • Simon H.L. Thomas, Elijah R. Behr, Pharmacological treatment of acquired QT prolongation and torsades de pointes, „British Journal of Clinical Pharmacology”, 81 (3), 2016, s. 420–427, DOI10.1111/bcp.12726, ISSN 1365-2125, PMID26183037, PMCIDPMC4767204 [dostęp 2020-04-28].
  • Kenji Hoshino i inni, Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome, „Pediatrics International: Official Journal of the Japan Pediatric Society”, 48 (2), 2006, s. 112–117, DOI10.1111/j.1442-200X.2006.02177.x, ISSN 1328-8067, PMID16635167 [dostęp 2020-04-28].
  • Silvia G. Priori i inni, 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), „Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology”, 17 (11), 2015, s. 1601–1687, DOI10.1093/europace/euv319, ISSN 1532-2092, PMID26318695 [dostęp 2020-04-28].

podyplomie.pl

uw.edu.pl

biol.uw.edu.pl

worldcat.org

  • Piotr Thor, Podstawy patofizjologii człowieka, Kraków: Fundacja Zdrowia Publicznego - Uniwersyteckie Wydawnictwo Medyczne "Vesalius", 2007, s. 305-307, ISBN 978-83-85688-78-5, OCLC 750115269 [dostęp 2020-04-28].
  • Jan Albert Nicolaas Groot, Leonore Ten Bokum, Hubertus Laurentius Antonius van den Oever, Late presentation of Torsades de Pointes related to fluoxetine following a multiple drug overdose, „Journal of Intensive Care”, 6, 2018, s. 59, DOI10.1186/s40560-018-0329-1, ISSN 2052-0492, PMID30214811, PMCIDPMC6131849 [dostęp 2020-04-28].
  • F. Dessertenne, [Ventricular tachycardia with 2 variable opposing foci], „Archives Des Maladies Du Coeur Et Des Vaisseaux”, 59 (2), 1966, s. 263–272, ISSN 0003-9683, PMID4956181 [dostęp 2020-04-28].
  • Ankavipar Saprungruang i inni, Genotype and clinical characteristics of congenital long QT syndrome in Thailand, „Indian Pacing and Electrophysiology Journal”, 18 (5), 2018, s. 165–171, DOI10.1016/j.ipej.2018.07.007, ISSN 0972-6292, PMID30036649, PMCIDPMC6198685 [dostęp 2020-04-28].
  • Peter J. Schwartz, Raymond L. Woosley, Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes, „Journal of the American College of Cardiology”, 67 (13), 2016, s. 1639–1650, DOI10.1016/j.jacc.2015.12.063, ISSN 1558-3597, PMID27150690 [dostęp 2020-04-28].
  • Pascal Champeroux i inni, Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres, „British Journal of Pharmacology”, 144 (3), 2005, s. 376–385, DOI10.1038/sj.bjp.0706070, ISSN 0007-1188 [dostęp 2020-04-28].
  • Sanoski i inni, Davis's drug guide for nurses, Fourteenth edition, Philadelphia, ISBN 978-0-8036-4085-6, OCLC 881473728 [dostęp 2020-04-28].
  • T.L. Lenz, D.E. Hilleman, Dofetilide, a new class III antiarrhythmic agent, „Pharmacotherapy”, 20 (7), 2000, s. 776–786, DOI10.1592/phco.20.9.776.35208, ISSN 0277-0008, PMID10907968 [dostęp 2020-04-28].
  • Tao Yang i inni, Screening for Acute IKr Block is Insufficient to Detect Torsades de Pointes Liability: Role of Late Sodium Current, „Circulation”, 130 (3), 2014, s. 224–234, DOI10.1161/circulationaha.113.007765, ISSN 0009-7322 [dostęp 2020-04-28].
  • Yee Guan Yap, A. John Camm, Drug induced QT prolongation and torsades de pointes, „Heart (British Cardiac Society)”, 89 (11), 2003, s. 1363–1372, DOI10.1136/heart.89.11.1363, ISSN 1468-201X, PMID14594906, PMCIDPMC1767957 [dostęp 2020-04-28].
  • Jinu John i inni, Torsade de Pointes due to Methadone Use in a Patient with HIV and Hepatitis C Coinfection, „Cardiology Research and Practice”, 2010, 2010, s. 524764, DOI10.4061/2010/524764, ISSN 2090-0597, PMID21253542, PMCIDPMC3021856 [dostęp 2020-04-28].
  • Simon H.L. Thomas, Elijah R. Behr, Pharmacological treatment of acquired QT prolongation and torsades de pointes, „British Journal of Clinical Pharmacology”, 81 (3), 2016, s. 420–427, DOI10.1111/bcp.12726, ISSN 1365-2125, PMID26183037, PMCIDPMC4767204 [dostęp 2020-04-28].
  • Kenji Hoshino i inni, Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome, „Pediatrics International: Official Journal of the Japan Pediatric Society”, 48 (2), 2006, s. 112–117, DOI10.1111/j.1442-200X.2006.02177.x, ISSN 1328-8067, PMID16635167 [dostęp 2020-04-28].
  • Silvia G. Priori i inni, 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), „Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology”, 17 (11), 2015, s. 1601–1687, DOI10.1093/europace/euv319, ISSN 1532-2092, PMID26318695 [dostęp 2020-04-28].